Therapeutic potential of apelin and Elabela in cardiovascular disease
Apelin and Elabela (Ela) are peptides encoded by APLN and APELA, respectively, which act on their receptor APJ and play crucial roles in the body. Recent research has shown that they not only have important effects on the endocrine system, but also promote vascular development and maintain the homeo...
Main Authors: | Shenghan Gao, Hongping Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223010594 |
Similar Items
-
The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
by: Natalia Respekta, et al.
Published: (2022-12-01) -
Advances in the study of ELABELA in renal physiological functions and related diseases
by: YuRong Liu, et al.
Published: (2023-10-01) -
The Apelinergic System in Pregnancy
by: Océane Pécheux, et al.
Published: (2023-04-01) -
Distribution, Function, and Expression of the Apelinergic System in the Healthy and Diseased Mammalian Brain
by: Martin N. Ivanov, et al.
Published: (2022-11-01) -
The G protein‐coupled receptor ligand apelin‐13 ameliorates skeletal muscle atrophy induced by chronic kidney disease
by: Yuki Enoki, et al.
Published: (2023-02-01)